Novel Use of All-Trans-Retinoic Acid in a Model of Lipopolysaccharide-Immunosuppression to Decrease the Generation of Myeloid-Derived Suppressor Cells by Reducing the Proliferation of CD34+ Precursor Cells
Shock - United States
doi 10.1097/shk.0000000000000812
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2017
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)